|4Jan 8, 4:57 PM ET

ALLEN LEE F MD PhD 4

4 · Dova Pharmaceuticals Inc. · Filed Jan 8, 2019

Insider Transaction Report

Form 4
Period: 2019-01-04
ALLEN LEE F MD PhD
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-01-04+9,07012,570 total
Footnotes (2)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 50% on each of June 30, 2019 and 25% on each of September 30, 2019 and December 31, 2019.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION